Clinical Study
Determinants of Thyrotoxic Cardiomyopathy Recovery
Table 4
Echocardiographic parameters at enrollment and at the 6 months followup.
| Parameters | | Referral | | | 6 months | | 25th percentile | Median | 75th percentile | 25th percentile | Median | 75th percentile |
| Complete reversibility | | | | | | | LVEF* | 45 | 48 | 50 | 55 | 58 | 60 | LVDD* | 50 | 52 | 53 | 43 | 45 | 46 | LVSD* | 30 | 31 | 32 | 27 | 27 | 28 | LVEDV* | 80 | 84 | 101 | 76 | 80 | 90 | LVESV* | 30 | 32 | 39 | 27 | 30 | 31 | Partial reversibility | | | | | | | LVEF* | 35 | 43 | 49 | 55 | 56 | 61 | LVDD* | 52 | 54 | 56 | 45 | 47 | 48 | LVSD* | 31 | 32 | 35 | 27 | 27 | 28 | LVEDV* | 87 | 100.5 | 108 | 80 | 94 | 99 | LVESV* | 34 | 40.5 | 44 | 30 | 35 | 38 | No reversibility | | | | | | | LVEF | 33 | 37 | 49 | 32 | 40 | 50 | LVDD | 54 | 55 | 56 | 49 | 54 | 57 | LVSD | 33 | 34 | 35 | 30 | 33 | 36 | LVEDV | 98 | 103 | 107 | 90 | 110 | 114 | LVESV | 35 | 39 | 41 | 30 | 40 | 45 |
|
|
MANOVA ANOVA . Note: LVEF: left ventricular ejection fraction (%), LVDD: left ventricular diastolic diameter (mm), LVSD: left ventricular systolic diameter (mm), LVEDV: left ventricular end-diastolic volume (mL), *LVESV: left ventricular end-systolic volume (mL).
|